SENS
Senseonics Holdings, Inc. · Healthcare
Insiders bought $517K of Senseonics Holdings, Inc. in the last 12 months
3 insiders bought on 4 days.
SENS over the last year
Largest buyers, last 12 months
SENS after insider buys
3 months after each buy, from the first price a copier could get.
7 buys since 2017 with 3 months of prices.
Every filing
56 insider filings since 2017, newest first
Douglas A Roeder · Director
Douglas A Roeder · Director
Douglas A Roeder · Director
Timothy T Goodnow · President and CEO
Edelman Steven · Director
Douglas A Roeder · Director
Douglas A Roeder · Director
Frederick T. Sullivan · CFO
Timothy T Goodnow · President and CEO
Mukul Jain · COO
Edward Fiorentino · Director
Nick B. Tressler · CFO
Mirasol Panlilio · VP Global Sales, Marketing
Francine Kaufman · Chief Medical Officer
Mukul Jain · COO
Kenneth L Horton · GC, Corp. Development Advisor
Timothy T Goodnow · President and CEO
Francine Kaufman · Chief Medical Officer
Mukul Jain · COO
Douglas A Roeder · Director
Mukul Jain · COO
Francine Kaufman · Chief Medical Officer
Timothy T Goodnow · President and CEO
Mukul Jain · COO
Francine Kaufman · Chief Medical Officer
Mukul Jain · COO
Douglas A Roeder · Director
Douglas S Prince · Director
Edward Fiorentino · Director
Edelman Steven · Director
Stephen P Defalco · Director
Mukul Jain · COO
Douglas A Roeder · Director
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
New Enterprise Associates 10 L P · 10% owner
Timothy T Goodnow · President and CEO
Timothy T Goodnow · President and CEO
Timothy T Goodnow · President and CEO
Mukul Jain · COO
Douglas A Roeder · Director
Douglas A Roeder · Director
Mukul Jain · COO
Mukul Jain · COO
Mukul Jain · COO
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.